Fair Value Measurements (Schedule Of Estimates Of Fair Value Of Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	$ 1,421,306	$ 1,338,137
Other securities	29,803	$ 30,966
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Other assets
Derivative Asset	566	$ 675
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Other liabilities
Net loans	4,252,854	$ 4,103,178
Accrued interest receivable	20,650	20,290
Carrying Amount
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	225,389	156,276
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	1,421,306	1,338,137
Other securities	6,157	7,538
Loans Receivable, Fair Value Disclosure		4,103,178
Accrued Interest Receivable Fair Value Disclosure		20,290
Derivative Asset	57,491	60,527
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits, Fair Value Disclosure	5,144,150	4,934,262
Short-term Debt, Fair Value	325,655	334,856
Accrued Interest Payable Fair Value Disclosure	6,798	4,301
Derivative Liability	51,257	48,578
Long-term Debt, Fair Value	150,000	100,000
Net loans	4,252,854
Accrued interest receivable	20,650
Fair Value
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	225,389	156,276
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	1,421,306	1,338,137
Other securities	6,157	7,538
Loans Receivable, Fair Value Disclosure		3,922,638
Accrued Interest Receivable Fair Value Disclosure		20,290
Derivative Asset	57,491	60,527
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits, Fair Value Disclosure	5,039,503	4,617,487
Short-term Debt, Fair Value	325,655	334,856
Accrued Interest Payable Fair Value Disclosure	6,798	4,301
Derivative Liability	51,257	48,578
Long-term Debt, Fair Value	149,137	99,928
Net loans	4,126,124
Accrued interest receivable	20,650
Level 1
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	225,389	156,276
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	0	0
Other securities	1,682	3,093
Loans Receivable, Fair Value Disclosure		0
Accrued Interest Receivable Fair Value Disclosure		0
Derivative Asset	0	0
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits, Fair Value Disclosure	3,799,701	3,591,458
Short-term Debt, Fair Value	0	0
Accrued Interest Payable Fair Value Disclosure	0	0
Derivative Liability	0	0
Long-term Debt, Fair Value	0	0
Net loans	0
Accrued interest receivable	0
Level 2
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	1,421,306	1,336,266
Other securities	4,475	4,445
Loans Receivable, Fair Value Disclosure		0
Accrued Interest Receivable Fair Value Disclosure		20,290
Derivative Asset	57,491	60,527
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits, Fair Value Disclosure	1,239,802	1,026,029
Short-term Debt, Fair Value	325,655	334,856
Accrued Interest Payable Fair Value Disclosure	6,798	4,301
Derivative Liability	51,257	48,578
Long-term Debt, Fair Value	149,137	99,928
Net loans	0
Accrued interest receivable	20,650
Level 3
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	0	0
Investment securities available for sale, at fair value (amortized cost $1,570,449 and $1,479,545, net of allowance for credit losses of $0 at December 31, 2024 and December 31, 2023, respectively)	0	1,871
Other securities	0	0
Loans Receivable, Fair Value Disclosure		3,922,638
Accrued Interest Receivable Fair Value Disclosure		0
Derivative Asset	0	0
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Deposits, Fair Value Disclosure	0	0
Short-term Debt, Fair Value	0	0
Accrued Interest Payable Fair Value Disclosure	0	0
Derivative Liability	0	0
Long-term Debt, Fair Value	0	$ 0
Net loans	4,126,124
Accrued interest receivable	$ 0